aliquot_line
TL3 Regular · Valladolid, ES
Wiki editor. Small, frequent, well-annotated edits.
Joined 13 October 2024 · last posted 7h · groups: wiki-editors
136 posts, newest first. Showing up to 150.
-
Compounds this community declines to help with, and why — does this still hold? Replied, post #8 · Compounds › Other compounds · 28 Jul 2026 · 8 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Coming back to: When a red flag was a misunderstanding, and the retraction Replied, post #11 · Sourcing › Red flags · 27 Jul 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Retatrutide mass and identity: what a report should show Replied, post #28 · Compounds › Retatrutide · 27 Jul 2026 · 18 likes Worth separating two things that post #24 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #50 · Practice › Interactions · 21 Jul 2026 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #98 · Practice › Administration · 19 Jul 2026 · 14 likes On post #94 — agreed on the reasoning, with one qualification. Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the…
-
Here for the analytics and not much else Replied, post #49 · Lounge › Introductions · 17 Jul 2026 · 14 likes No spam: introductions are not a place to advertise commercial products or services. That is a rules violation.
-
Pooling trials with different estimands Replied, post #101 · Evidence › Meta-analyses · 16 Jul 2026 · 2 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Which categories are strict and which are relaxed, honestly Replied, post #15 · Start Here › Welcome · 14 Jul 2026 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #16 · Evidence › Study critique · 13 Jul 2026 · 28 likes This follows post #13 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Why this subcategory is stricter about sourcing than most Replied, post #50 · Compounds › Secretagogues & GH axis · 1 Jul 2026 · 8 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Electrolyte supplements: which ones do anything Replied, post #43 · Nutrition & Training › Hydration & electrolytes · 30 Jun 2026 · 6 likes post #42 answers the question as asked. The question underneath it is different. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #56 · Analytics › HPLC & UHPLC · 21 Jun 2026 · 13 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Journal club: what we got wrong in an earlier session Replied, post #17 · Evidence › Journal club · 20 Jun 2026 · 2 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Transporting a vial for a weekend away — a second dataset Replied, post #85 · Practice › Storage & stability · 17 Jun 2026 · 5 likes Coming back to post #83, because the follow-up matters more than the original answer. Container choice matters: the material of the vial, the rubber closure, the fill…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #24 · Documentation › Doc review · 16 Jun 2026 · 2 likes On post #20 — agreed on the reasoning, with one qualification. Evidence synthesis requests: if you think a page should summarise the state of evidence on a question,…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #55 · Analytics › Home & field testing · 15 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: what we got wrong in an earlier session Replied, post #3 · Evidence › Journal club · 13 Jun 2026 · 32 likes post #2 answers the question as asked. The question underneath it is different. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg.…
-
Insurance and replacement policies, compared Replied, post #16 · Sourcing › Logistics · 12 Jun 2026 · 6 likes post #15 answers the question as asked. The question underneath it is different. Tracking stops updating: tracking last updated days ago usually means the package is in…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #73 · Practice › Administration · 4 Jun 2026 · 25 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
What steady state means for the decision to escalate Replied, post #8 · Practice › Dosing & titration · 1 Jun 2026 · 28 likes I read post #6 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Search filters: what is missing Replied, post #64 · Meta › Site feedback · 1 Jun 2026 · 5 likes post #63 is right about the mechanism and I think understates the practical bit. Community norms: if you think a norm has drifted or is not being followed consistently,…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #33 · Practice › Storage & stability · 31 May 2026 · 26 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #54 · Sourcing › Red flags · 29 May 2026 · 13 likes On post #50 — agreed on the reasoning, with one qualification. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a…
-
What a good consultation looks like from the other side Replied, post #44 · Clinical › Prescriber conversations · 27 May 2026 · 1 like I read post #42 twice before replying, because I had assumed the opposite. Preparing for an appointment: bring recent bloodwork, a list of current medications with…
-
The best-written scientific paper you have read Replied, post #54 · Lounge › Off topic · 19 May 2026 · 2 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Tracking a shortage from primary sources rather than rumour Replied, post #12 · Access › Shortages · 17 May 2026 · 21 likes I read post #10 twice before replying, because I had assumed the opposite. Supply interruptions: official shortage notices are published by regulatory agencies. That is…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #48 · Compounds › Tirzepatide · 13 May 2026 · 11 likes post #47 answers the question as asked. The question underneath it is different. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
[2026 update] What a good consultation looks like from the other side Replied, post #31 · Clinical › Prescriber conversations · 13 May 2026 · 1 like Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #37 · Analytics › COA interpretation · 8 May 2026 · 25 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Request: show the solution author in the topic list — what changed since Replied, post #70 · Meta › Feature requests · 3 May 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Prescription requirements and telehealth models — a second dataset Replied, post #15 · Sourcing › Regulatory · 29 Apr 2026 · 5 likes Worth separating two things that post #11 runs together. Research-use-only status is a legal classification, not a safety classification. It means the compound is sold…
-
Personal import allowances, compared — a second dataset Replied, post #113 · Access › International · 29 Apr 2026 · 27 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #52 · Data & Tools › Datasets · 16 Apr 2026 · 0 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #5 · Practice › Reconstitution · 15 Apr 2026 · 8 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #98 · Practice › Reconstitution · 14 Apr 2026 · 2 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Sample handling between despatch and injection Replied, post #32 · Analytics › Method validation · 11 Apr 2026 · 26 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #12 · Sourcing › Independent verification · 8 Apr 2026 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: State-level differences that actually matter Replied, post #64 · Regional › North America · 7 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: State-level differences that actually matter Replied, post #11 · Regional › North America · 4 Apr 2026 · 30 likes Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #45 · Research Methods › N-of-1 designs · 8 Mar 2026 · 10 likes Picking up post #42: that is the part I would want checked first. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one…
-
Follow-up: Request: a per-category review queue Started this topic · Meta › Feature requests · 7 Mar 2026 · 8 likes On the subject in the title: Request: a per-category review queue Working notes rather than a conclusion. Nominating something for promotion into the documentation…
-
Preprint servers and what screening they do Replied, post #73 · Evidence › Preprints · 1 Mar 2026 · 1 like Picking up post #70: that is the part I would want checked first. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data,…
-
The lowest dose that does anything: is that a real question? Replied, post #8 · Practice › Dosing & titration · 1 Mar 2026 · 3 likes Worth separating two things that post #4 runs together. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years…
-
Conditions that change the calculus rather than forbidding it Started this topic · Safety › Contraindications · 23 Feb 2026 · 0 likes Conditions that change the calculus rather than forbidding it Writing it up because I had to work it out twice and would rather nobody else did. Asking about a…
-
Request: export my own posts — one year on Replied, post #50 · Meta › Feature requests · 22 Feb 2026 · 4 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.
-
Request declined, with reasoning — what changed since Replied, post #14 · Meta › Feature requests · 19 Feb 2026 · 29 likes post #13 is right about the mechanism and I think understates the practical bit. Effort estimation: some features are trivial to implement; others are substantial work.…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #52 · Clinical › Bloodwork · 18 Feb 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #79 · Analytics › Mass spectrometry · 14 Feb 2026 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #42 · Pharmacology › Pharmacokinetics · 14 Feb 2026 · 0 likes Worth separating two things that post #38 runs together. Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these…
-
Trifluoroacetate content and its consequences Replied, post #127 · Analytics › Impurities & related substances · 11 Feb 2026 · 32 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Preprint servers and what screening they do Replied, post #42 · Evidence › Preprints · 1 Feb 2026 · 11 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
[2026 update] What a purity-only report leaves out Replied, post #7 · Sourcing › Independent verification · 23 Jan 2026 · 8 likes Worth separating two things that post #3 runs together. How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity,…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #75 · Sourcing › Independent verification · 10 Jan 2026 · 6 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #48 · Pharmacology › Receptor biology · 8 Jan 2026 · 0 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
Heterogeneity as information rather than as a nuisance Replied, post #52 · Evidence › Meta-analyses · 6 Jan 2026 · 23 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #25 · Compounds › Retatrutide · 22 Dec 2025 · 4 likes post #24 answers the question as asked. The question underneath it is different. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #17 · Pharmacology › Receptor biology · 18 Dec 2025 · 0 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Batch date after test date, and other internal inconsistencies Replied, post #26 · Analytics › COA interpretation · 12 Dec 2025 · 19 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Documentation that materially improves an appeal's chances Replied, post #90 · Access › Insurance & coverage · 5 Dec 2025 · 0 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
[2026 update] Long-time reader, first-time poster Replied, post #30 · Lounge › Introductions · 3 Dec 2025 · 1 like No spam: introductions are not a place to advertise commercial products or services. That is a rules violation.
-
What pooling buys you and what it destroys Replied, post #82 · Evidence › Meta-analyses · 3 Dec 2025 · 26 likes post #81 is right about the mechanism and I think understates the practical bit. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #99 · Documentation › Doc review · 24 Nov 2025 · 4 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Pen dose counters: what a click does and does not guarantee Replied, post #56 · Devices › Pens & autoinjectors · 16 Nov 2025 · 2 likes post #55 is right about the mechanism and I think understates the practical bit. Reusability: some pens are single-use (throw away after one injection). Others can be…
-
MHRA statements, read directly Replied, post #31 · Regional › UK & Ireland · 14 Nov 2025 · 29 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Personal import allowances, compared — a second dataset Replied, post #18 · Access › International · 5 Nov 2025 · 1 like Worth separating two things that post #14 runs together. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it…
-
Publishing an inconvenient result: a case study — the long version Replied, post #27 · Sourcing › Independent verification · 4 Nov 2025 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. Repeat testing: if you want to verify the same lot a second time, testing with a different…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #19 · Compounds › Tirzepatide · 3 Nov 2025 · 7 likes Picking up post #16: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #4 · Compounds › Semaglutide · 18 Oct 2025 · 10 likes On the opening post — agreed on the reasoning, with one qualification. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #88 · Practice › Storage & stability · 17 Oct 2025 · 3 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #24 · Compounds › Semaglutide · 10 Oct 2025 · 6 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #25 · Analytics › HPLC & UHPLC · 8 Oct 2025 · 13 likes post #24 is right about the mechanism and I think understates the practical bit. Gradient slope is the single biggest driver of apparent purity differences. A shallower…
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #7 · Compounds › Tirzepatide · 26 Sep 2025 · 14 likes post #6 answers the question as asked. The question underneath it is different. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Moderation log format change Started this topic · Meta › Announcements · 25 Sep 2025 · 16 likes Posting this under the heading it deserves: Moderation log format change Everything below is what sits behind that. Process question about how this site works. I have…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #42 · Compounds › Other compounds · 12 Sep 2025 · 18 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #53 · Practice › Side effects · 11 Sep 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #10 · Data & Tools › Datasets · 6 Sep 2025 · 15 likes This follows post #7 rather than contradicting it. Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed.…
-
Theoretical plates: useful number or ritual? Replied, post #2 · Analytics › HPLC & UHPLC · 4 Sep 2025 · 6 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
High-resolution MS on aggregates and what it can see Replied, post #59 · Analytics › Mass spectrometry · 3 Sep 2025 · 20 likes Coming back to post #57, because the follow-up matters more than the original answer. Calibration matters: a high-resolution instrument out of calibration can report…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #16 · Data & Tools › Datasets · 1 Sep 2025 · 0 likes post #15 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Tag proliferation and whether we should prune Started this topic · Meta › Site feedback · 1 Sep 2025 · 37 likes On the subject in the title: Tag proliferation and whether we should prune Working notes rather than a conclusion. Process question about how this site works. I have…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #113 · Compounds › Repair & healing peptides · 24 Aug 2025 · 7 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #61 · Clinical › Special populations · 16 Aug 2025 · 0 likes This follows post #58 rather than contradicting it. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal…
-
A request that was declined, and the reasoning — a second dataset Replied, post #83 · Documentation › Wiki requests · 14 Aug 2025 · 0 likes Worth separating two things that post #79 runs together. Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a…
-
Thyroid function tests during substantial weight change Replied, post #21 · Clinical › Bloodwork · 4 Aug 2025 · 12 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #101 · Wellbeing › Mental health · 31 Jul 2025 · 0 likes I read post #99 twice before replying, because I had assumed the opposite. When to involve a professional: if mood changes are persistent, deepen over weeks, or…
-
Follow-up: Why appetite effects are mostly central Replied, post #7 · Pharmacology › Receptor biology · 28 Jul 2025 · 0 likes post #6 answers the question as asked. The question underneath it is different. Long-term receptor changes: very little is known about what happens to receptor…
-
Sequence verification for an obscure compound: how it is done Replied, post #106 · Compounds › Other compounds · 27 Jul 2025 · 31 likes On post #102 — agreed on the reasoning, with one qualification. This subcategory exists because some people will research compounds outside the main groups discussed…
-
Canadian access and provincial variation — one year on Replied, post #31 · Regional › North America · 26 Jul 2025 · 8 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
Which panel is worth repeating and which is worth ignoring Replied, post #55 · Clinical › Bloodwork · 7 Jul 2025 · 27 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Sodium, potassium and magnesium when intake drops Replied, post #46 · Nutrition & Training › Hydration & electrolytes · 6 Jul 2025 · 20 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
-
Discussing something you have already been doing — the long version Replied, post #3 · Clinical › Prescriber conversations · 4 Jul 2025 · 6 likes I read the opening post twice before replying, because I had assumed the opposite. Discussing off-label dosing: if you want to dose differently than the label specifies…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #64 · Pharmacology › Pharmacokinetics · 25 Jun 2025 · 25 likes Coming back to post #62, because the follow-up matters more than the original answer. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days.…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #51 · Pharmacology › Pharmacokinetics · 18 Jun 2025 · 13 likes Worth separating two things that post #47 runs together. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #56 · Evidence › Journal club · 13 Jun 2025 · 3 likes post #55 answers the question as asked. The question underneath it is different. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an…
-
Reverting an edit that had no revision note Replied, post #9 · Meta › Wiki maintenance · 8 Jun 2025 · 1 like Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
Sequence verification for an obscure compound: how it is done Replied, post #49 · Compounds › Other compounds · 31 May 2025 · 5 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #41 · Evidence › Trials · 30 May 2025 · 32 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Which panel is worth repeating and which is worth ignoring Replied, post #28 · Clinical › Bloodwork · 30 May 2025 · 27 likes post #27 answers the question as asked. The question underneath it is different. TSH and free hormones: TSH is a reasonable screening test but does not tell you about…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #56 · Compounds › Other compounds · 20 May 2025 · 21 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Reading a trial's population section before its results — does this still hold? Replied, post #118 · Evidence › Trials · 18 May 2025 · 1 like post #117 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Why the timeline is on the right and not the left Replied, post #18 · Meta › Site feedback · 16 May 2025 · 16 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
-
A claim built entirely on a subgroup analysis Replied, post #36 · Evidence › Study critique · 15 May 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #25 · Nutrition & Training › Protein & intake · 15 May 2025 · 7 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
About the Repair & healing peptides category Replied, post #4 · Compounds › Repair & healing peptides · 12 May 2025 · 7 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #6 · Compounds › Repair & healing peptides · 2 May 2025 · 22 likes post #5 is right about the mechanism and I think understates the practical bit. Stability of BPC-157 in solution: what has been measured in published work covers…
-
Reading order for a first week here, and what to skip until later Replied, post #108 · Start Here › Welcome · 29 Apr 2025 · 4 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #21 · Sourcing › Independent verification · 27 Apr 2025 · 27 likes On post #17 — agreed on the reasoning, with one qualification. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Coverage for the indication versus for the drug Replied, post #44 · Access › Insurance & coverage · 27 Apr 2025 · 7 likes Picking up post #41: that is the part I would want checked first. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #7 · Nutrition & Training › Protein & intake · 23 Apr 2025 · 15 likes post #6 answers the question as asked. The question underneath it is different. Eating anything at all: on substantial appetite suppression, eating enough total…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #135 · Sourcing › Regulatory · 23 Apr 2025 · 12 likes post #134 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
When "no data" is the complete and final answer Replied, post #147 · Compounds › Other compounds · 13 Apr 2025 · 33 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #74 · Practice › Reconstitution · 8 Apr 2025 · 9 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Retatrutide dose escalation in the published trials Replied, post #55 · Compounds › Retatrutide · 27 Mar 2025 · 1 like How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Scheduled maintenance and what will be unavailable Replied, post #80 · Meta › Announcements · 21 Mar 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #87 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Coming back to post #85, because the follow-up matters more than the original answer. Date the report: when the analysis was done matters. Material can degrade in…
-
When "no data" is the complete and final answer Replied, post #118 · Compounds › Other compounds · 14 Mar 2025 · 0 likes Coming back to post #116, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Validating a method you did not develop — does this still hold? Replied, post #37 · Analytics › Method validation · 23 Feb 2025 · 0 likes post #36 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
What we do not know about retatrutide, listed explicitly Replied, post #97 · Compounds › Retatrutide · 15 Feb 2025 · 28 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #120 · Evidence › Journal club · 8 Feb 2025 · 7 likes This follows post #117 rather than contradicting it. Session format: read the paper before posting. The discussion is much better when everyone has. Start with the…
-
Protein density versus volume when you cannot eat much Replied, post #89 · Nutrition & Training › Protein & intake · 8 Feb 2025 · 1 like Picking up post #86: that is the part I would want checked first. Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #79 · Data & Tools › Calculators · 6 Feb 2025 · 19 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #17 · Access › International · 28 Jan 2025 · 2 likes On post #13 — agreed on the reasoning, with one qualification. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers.…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #7 · Analytics › COA interpretation · 15 Jan 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #63 · Compounds › Semaglutide · 22 Dec 2024 · 7 likes post #62 answers the question as asked. The question underneath it is different. The SELECT trial changed the positioning because it was the first cardiovascular…
-
A page that has drifted out of date and needs a maintainer Replied, post #40 · Documentation › Wiki requests · 16 Dec 2024 · 17 likes Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #20 · Clinical › Special populations · 7 Dec 2024 · 0 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
EMA product information as a primary source — does this still hold? Replied, post #132 · Regional › European Union · 18 Nov 2024 · 11 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
-
The topic list is dense — is that deliberate? Replied, post #53 · Meta › Site feedback · 16 Nov 2024 · 0 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #30 · Sourcing › Independent verification · 13 Nov 2024 · 2 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #15 · Compounds › Semaglutide · 7 Nov 2024 · 15 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Blind submission and why it changes minds Replied, post #82 · Sourcing › Independent verification · 8 Oct 2024 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #65 · Sourcing › Independent verification · 17 Sep 2024 · 0 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #8 · Analytics › Impurities & related substances · 25 Aug 2024 · 26 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #16 · Devices › Syringes & needles · 2 Aug 2024 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The mass-error checker and its intended scope Replied, post #123 · Data & Tools › Calculators · 14 Jul 2024 · 29 likes post #122 is right about the mechanism and I think understates the practical bit. Why calculators are not medical advice: they do arithmetic. Medical decisions are not…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #33 · Practice › Dosing & titration · 7 Jul 2024 · 17 likes Coming back to post #31, because the follow-up matters more than the original answer. The four-week escalation interval is a convention from the pivotal trials, not a…